TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33054054 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 33054084 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 33054084 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33054084 — Predictive Biomarker (PRD): RPS15 mRNA
Genes: RPS15; RIG
Study 33054084 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 33054084 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study 33054130 — Predictive Biomarker (PRD): TMPRSS6 mRNA
Genes: TMPRSS6; UNQ354/PRO618
Study 33057634 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33058182 — Surrogate Endpoint (SUR): Blood pressure
Study 33058496 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 33058496 — Surrogate Endpoint (SUR): Serum creatinine
Study 33059645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33059715 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study 33060077 — Predictive Biomarker (PRD): KRT5 mRNA
Genes: KRT5
Study 33060077 — Predictive Biomarker (PRD): KRT14 mRNA
Genes: KRT14
Study 33060077 — Predictive Biomarker (PRD): FOXA1 mRNA
Genes: FOXA1; HNF3A; TCF3A
Study 33060077 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 33060077 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33060149 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33060506 — Surrogate Endpoint (SUR): Serum creatinine
Study 33061347 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33062063 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33062063 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33062063 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 33062236 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33063141 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33064988 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33066188 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 33066724 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 33066801 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33067126 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33067297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33067318 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33067379 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33067633 — Predictive Biomarker (PRD): F9 mRNA
Genes: F9
Study 33067775 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 33068284 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 33068794 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33069849 — Predictive Biomarker (PRD): IVL mRNA
Genes: IVL
Study 33070307 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33070307 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33071007 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33071206 — Surrogate Endpoint (SUR): Blood pressure
Study 33071206 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33072126 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33072399 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 33072620 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 33072814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33073557 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33073631 — Surrogate Endpoint (SUR): Blood pressure
Study 33074330 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33074330 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 33074401 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33075344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33078867 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33078867 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33079376 — Predictive Biomarker (PRD): PPP1R12A mRNA
Genes: PPP1R12A; MBS; MYPT1
Study 33079880 — Surrogate Endpoint (SUR): Blood pressure
Study 33080003 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33080911 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33082208 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33082208 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 33083026 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33083050 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33083685 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33084880 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD
Study 33084880 — Predictive Biomarker (PRD): SLC12A1 mRNA
Genes: SLC12A1; NKCC2
Study 33084880 — Surrogate Endpoint (SUR): Blood pressure
Study 33087092 — Monitoring Biomarker (MOI): Procalcitonin
Study 33087092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33087116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33087116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33087142 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33087142 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33087150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33087345 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33087380 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study 33088015 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33089005 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33089304 — Pharmacodynamic Biomarker (PDY): miR-132
Genes: MIR132
Study 33089502 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 33089502 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33089502 — Surrogate Endpoint (SUR): Blood pressure
Study 33089874 — Predictive Biomarker (PRD): NEDD8 mRNA
Genes: NEDD8
Study 33090333 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33090333 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 33090970 — Monitoring Biomarker (MOI): HBV DNA
Study 33092403 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33092438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33092646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33092646 — Surrogate Endpoint (SUR): Blood pressure
Study 33093033 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33093337 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33093337 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33093337 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 33093337 — Predictive Biomarker (PRD): Hormone receptor
Study 33093408 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 33094826 — Surrogate Endpoint (SUR): Blood pressure
Study 33095411 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33095874 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 33096421 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 33096476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33096476 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study 33096476 — Predictive Biomarker (PRD): CASP8 mRNA
Genes: CASP8; MCH5
Study 33096476 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 33097085 — Predictive Biomarker (PRD): CREBBP mRNA
Genes: CREBBP; CBP
Study 33097085 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 33097612 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 33098195 — Surrogate Endpoint (SUR): Pathological complete response
Study 33098553 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 33098553 — Surrogate Endpoint (SUR): Serum triglycerides
Study 33099678 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 33101409 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 33101409 — Predictive Biomarker (PRD): APOB mRNA
Genes: APOB
Study 33101409 — Predictive Biomarker (PRD): APOA1 mRNA
Genes: APOA1
Study 33101775 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study 33102391 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33103591 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33104056 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33104201 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33104201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33104838 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 33104865 — Predictive Biomarker (PRD): GPR119 mRNA
Genes: GPR119
Study 33104865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33104972 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33107145 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 33107145 — Predictive Biomarker (PRD): JUN mRNA
Genes: JUN
Study 33107191 — Predictive Biomarker (PRD): PARD3 mRNA
Genes: PARD3; PAR3; PAR3A
Study 33107189 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33107592 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33107592 — Surrogate Endpoint (SUR): Serum creatinine
Study 33107592 — Surrogate Endpoint (SUR): Blood pressure
Study 33107592 — Surrogate Endpoint (SUR): Serum potassium
Study 33109210 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33109210 — Predictive Biomarker (PRD): Hormone receptor
Study 33109667 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 33109675 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 33109737 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33109737 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33110944 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33112968 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 33113214 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 33114652 — Predictive Biomarker (PRD): PKN3 mRNA
Genes: PKN3; PKNBETA
Study 33114652 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 33115815 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33115815 — Predictive Biomarker (PRD): Hormone receptor
Study 33116464 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33116698 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33117454 — Surrogate Endpoint (SUR): Serum uric acid
Study 33119476 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33119476 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33119478 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study 33119479 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33119664 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 33119664 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33121236 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study 33121236 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 33121236 — Safety Biomarker (SAF): Complement factor D
Genes: CFD; DF; PFD
Study 33121236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33122421 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 33122578 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33122578 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33122578 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33122898 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 33123048 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study 33125520 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 33125520 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33125520 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 33125909 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33125909 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33126339 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33128179 — Surrogate Endpoint (SUR): Blood pressure
Study 33128299 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 33128299 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33128785 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study 33128796 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 33128873 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 33128903 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33130216 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study 33130216 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33130216 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 33130518 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 33131933 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33132098 — Surrogate Endpoint (SUR): Blood pressure
Study 33132098 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33134423 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 33134423 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33137293 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 33137635 — Surrogate Endpoint (SUR): Blood pressure
Study 33138835 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33138839 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 33138839 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 33138839 — Predictive Biomarker (PRD): CXCL2 mRNA
Genes: CXCL2; GRO2; GROB; MIP2A; SCYB2
Study 33138839 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 33138839 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33138839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 33138839 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 33138839 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33138839 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 33138839 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 33138839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 33138848 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33138866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33138866 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 33138866 — Predictive Biomarker (PRD): INPP4B mRNA
Genes: INPP4B
Study 33138866 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33138866 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 33138974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33139139 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33139266 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33139388 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 33140664 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33141101 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33141170 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33141172 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33142006 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 33142006 — Surrogate Endpoint (SUR): Blood pressure
Study 33142018 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 33142018 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 33142029 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33142029 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33145402 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33145809 — Surrogate Endpoint (SUR): Bone mineral density
Study 33146854 — Monitoring Biomarker (MOI): Procalcitonin
Study 33146854 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33147119 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 33147613 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 33147613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33148185 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 33148330 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 33148330 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33148693 — Predictive Biomarker (PRD): Microsatellite instability
Study 33148961 — Surrogate Endpoint (SUR): Blood pressure
Study 33148977 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33149768 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33149768 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33150375 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33150390 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33150390 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33152759 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 33152759 — Predictive Biomarker (PRD): KMT2D mRNA
Genes: KMT2D; ALR; MLL2; MLL4
Study 33153580 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33153629 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33153629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33153629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33154826 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 33155938 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 33156107 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study 33157979 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 33157979 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study 33157979 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 33157979 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 33159213 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33159216 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33159216 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33159216 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33159275 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 33159841 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33159841 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33160700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33160848 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33161240 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 33161240 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 33161240 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33161899 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33163109 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study 33164349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33164349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33165755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33167773 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33167995 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33170310 — Surrogate Endpoint (SUR): Blood pressure
Study 33170484 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1